EGFR and neoplasm: In an exploratory study of 40 patients with EGFR mutation-positive tumors progressing on EGFR TKI therapy, the T790M genotype from tumor biopsies was compared with findings from simultaneously collected circulating tumor cells and circulating tumor DNA [65].